As part of our mission to end suffering and death due to melanoma, we have partnered with Antidote, a digital health company that uses cutting-edge technology to match the right patients with the right clinical trials. Patients can now match to clinical trials using our Clinical Trial Locator, powered by Antidote.
In addition, Antidote also offers researchers the opportunity to make their trial listings more patient-friendly through a free tool called Antidote Bridge. Bridge allows researchers to enhance their study pages with details that are most important to patients - things like number of overnight stays, financial compensation, and procedures used. This additional information helps close the information gap between patients and researchers, which ultimately leads to greater patient engagement.
As an MRA-affiliated researcher, we encourage you to take the time to register for Bridge and begin providing patients with as much information as possible to help them make informed clinical trial decisions.